PAUL STEVEN M — SEC Form 4 filings
SEC reporting owner CIK 1237564. 9 Form 4 filings on record with FilingPulse; latest filed 2026-06-10.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-01-04 to 2026-06-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 1 filing — 41,666 shares, $1,027,111 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 37.
- Largest priced transaction: purchase of 28,284 shares @ $24.50 ($692,947) in Rapport Therapeutics, Inc., filed 2025-09-15.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Rapport Therapeutics, Inc. (RAPP) | Director | 3 | 2 legs · 41,666 sh · $1,027,111 | — | 2 |
| Karuna Therapeutics, Inc. (KRTX) | Director | 4 | — | — | 30 |
| Seaport Therapeutics, Inc. (SPTX) | Director | 1 | — | — | 4 |
| Sage Therapeutics, Inc. (SAGE) | Director | 1 | — | — | 1 |
Form 4 filings — PAUL STEVEN M
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-10 | 4 | Rapport Therapeutics, Inc. (RAPP) | Grant/award (A): 15,200 (derivative) @ $0 | EDGAR |
| 2026-05-04 | 4 | Seaport Therapeutics, Inc. (SPTX) | Conversion (C): 67,031 · Grant/award (A): 12,258 (derivative) @ $0 · Grant/award (A): 991,192 (derivative) @ $0 · Conversion (C): 210,526 (derivative) @ $0 | EDGAR |
| 2025-09-15 | 4 | Rapport Therapeutics, Inc. (RAPP) | Purchase (P): 28,284 @ $24.50 · Purchase (P): 13,382 @ $24.97 | EDGAR |
| 2025-06-18 | 4 | Rapport Therapeutics, Inc. (RAPP) | Grant/award (A): 21,850 (derivative) @ $0 | EDGAR |
| 2024-03-18 | 4 | Karuna Therapeutics, Inc. (KRTX) | Disposition to issuer (D): 2,046 @ $330 · Disposition to issuer (D): 8,550 @ $330 · Disposition to issuer (D): 30,304 @ $330 · Disposition to issuer (D): 10,000 @ $330 · Disposition to issuer (D): 33,882 @ $330 · Disposition to issuer (D): 30,304 @ $330 · +12 more | EDGAR |
| 2024-03-04 | 4 | Karuna Therapeutics, Inc. (KRTX) | Other (J): 47,378 @ $315.18 · Gift (G): 30,304 @ $0 · Gift (G): 30,304 @ $0 · Gift (G): 30,304 @ $0 · Gift (G): 30,304 @ $0 · Gift (G): 30,304 @ $0 · +1 more | EDGAR |
| 2024-02-26 | 4 | Karuna Therapeutics, Inc. (KRTX) | Option exercise (M): 27,510 @ $7.27 · Option exercise (M): 4,008 @ $99.72 · Option exercise (M): 27,510 (derivative) @ $0 · Option exercise (M): 4,008 (derivative) @ $0 | EDGAR |
| 2024-02-12 | 4 | Karuna Therapeutics, Inc. (KRTX) | Tax withholding (F): 804 @ $317.14 | EDGAR |
| 2024-01-04 | 4 | Sage Therapeutics, Inc. (SAGE) | Grant/award (A): 3,971 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-04 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1237564 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →